187 related articles for article (PubMed ID: 38519456)
1. Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis.
Hilwi M; Shulman K; Naroditsky I; Feld S; Gross-Cohen M; Boyango I; Soboh S; Vornicova O; Farhoud M; Singh P; Bar-Sela G; Goldberg H; Götte M; Sharrocks AD; Li Y; Sanderson RD; Ilan N; Vlodavsky I
Cell Death Dis; 2024 Mar; 15(3):232. PubMed ID: 38519456
[TBL] [Abstract][Full Text] [Related]
2. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.
Gross-Cohen M; Yanku Y; Kessler O; Barash U; Boyango I; Cid-Arregui A; Neufeld G; Ilan N; Vlodavsky I
Matrix Biol; 2021 May; 99():58-71. PubMed ID: 34004353
[TBL] [Abstract][Full Text] [Related]
3. A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane.
Margulis I; Naroditsky I; Gross-Cohen M; Ilan N; Vlodavsky I; Doweck I
Front Oncol; 2021; 11():645524. PubMed ID: 33959505
[TBL] [Abstract][Full Text] [Related]
4. Heparanase 2 (Hpa2) attenuates the growth of human sarcoma.
Knani I; Yanku Y; Gross-Cohen M; Ilan N; Vlodavsky I
Matrix Biol; 2022 Nov; 113():22-38. PubMed ID: 36122821
[TBL] [Abstract][Full Text] [Related]
5. Role of heparanase 2 (Hpa2) in gastric cancer.
Liu J; Knani I; Gross-Cohen M; Hu J; Wang S; Tang L; Ilan N; Yang S; Vlodavsky I
Neoplasia; 2021 Sep; 23(9):966-978. PubMed ID: 34343822
[TBL] [Abstract][Full Text] [Related]
6. Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.
Gross-Cohen M; Feld S; Doweck I; Neufeld G; Hasson P; Arvatz G; Barash U; Naroditsky I; Ilan N; Vlodavsky I
Cancer Res; 2016 May; 76(9):2791-801. PubMed ID: 27013193
[TBL] [Abstract][Full Text] [Related]
7. Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma.
Kayal Y; Singh P; Naroditsky I; Ilan N; Vlodavsky I
Matrix Biol; 2021 Apr; 98():21-31. PubMed ID: 33839221
[TBL] [Abstract][Full Text] [Related]
8. Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.
Gross-Cohen M; Feld S; Naroditsky I; Nativ O; Ilan N; Vlodavsky I
Oncotarget; 2016 Apr; 7(16):22556-65. PubMed ID: 26968815
[TBL] [Abstract][Full Text] [Related]
9. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
[TBL] [Abstract][Full Text] [Related]
10. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.
Knani I; Singh P; Gross-Cohen M; Aviram S; Ilan N; Sanderson RD; Aronheim A; Vlodavsky I
Matrix Biol; 2022 Jan; 105():17-30. PubMed ID: 34808335
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Consequences of Heparan Sulfate Binding by Heparanase 2.
Gross-Cohen M; Feld S; Arvatz G; Ilan N; Vlodavsky I
Front Oncol; 2020; 10():627463. PubMed ID: 33585253
[TBL] [Abstract][Full Text] [Related]
12. Opposing Effects of Heparanase and Heparanase-2 in Head & Neck Cancer.
Doweck I; Feibish N
Adv Exp Med Biol; 2020; 1221():847-856. PubMed ID: 32274741
[TBL] [Abstract][Full Text] [Related]
13. Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
Levy-Adam F; Feld S; Cohen-Kaplan V; Shteingauz A; Gross M; Arvatz G; Naroditsky I; Ilan N; Doweck I; Vlodavsky I
J Biol Chem; 2010 Sep; 285(36):28010-9. PubMed ID: 20576607
[TBL] [Abstract][Full Text] [Related]
14. Human heparanase nuclear localization and enzymatic activity.
Schubert SY; Ilan N; Shushy M; Ben-Izhak O; Vlodavsky I; Goldshmidt O
Lab Invest; 2004 May; 84(5):535-44. PubMed ID: 15034597
[TBL] [Abstract][Full Text] [Related]
15. Heparanase-A single protein with multiple enzymatic and nonenzymatic functions.
Vlodavsky I; Kayal Y; Hilwi M; Soboh S; Sanderson RD; Ilan N
Proteoglycan Res; 2023 Jul; 1(3):e6. PubMed ID: 37547889
[TBL] [Abstract][Full Text] [Related]
16. Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation.
Kayal Y; Barash U; Naroditsky I; Ilan N; Vlodavsky I
Cell Death Dis; 2023 Jul; 14(7):465. PubMed ID: 37491420
[TBL] [Abstract][Full Text] [Related]
17. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
18. Heparanase-The Message Comes in Different Flavors.
Ilan N; Bhattacharya U; Barash U; Boyango I; Yanku Y; Gross-Cohen M; Vlodavsky I
Adv Exp Med Biol; 2020; 1221():253-283. PubMed ID: 32274713
[TBL] [Abstract][Full Text] [Related]
19. Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.
Peretti T; Waisberg J; Mader AM; de Matos LL; da Costa RB; Conceição GM; Lopes AC; Nader HB; Pinhal MA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):756-65. PubMed ID: 18617780
[TBL] [Abstract][Full Text] [Related]
20. Localization of heparanase in esophageal cancer cells: respective roles in prognosis and differentiation.
Ohkawa T; Naomoto Y; Takaoka M; Nobuhisa T; Noma K; Motoki T; Murata T; Uetsuka H; Kobayashi M; Shirakawa Y; Yamatsuji T; Matsubara N; Matsuoka J; Haisa M; Gunduz M; Tsujigiwa H; Nagatsuka H; Hosokawa M; Nakajima M; Tanaka N
Lab Invest; 2004 Oct; 84(10):1289-304. PubMed ID: 15286661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
